TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM
$19.6M
This Quarter Return
+3.03%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$38M
AUM Growth
+$38M
(-84%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-337.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
–
Increased
–
Reduced
2
Closed
3
Top Buys
No buys this quarter
Top Sells
| 1 |
Denali Therapeutics
DNLI
|
$97.9M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$16M |
| 3 |
American Well
AMWL
|
$14M |
| 4 |
AKLI
Akili, Inc. Common Stock
AKLI
|
$321K |
| 5 |
Rani Therapeutics
RANI
|
$25.9K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
HilleVax
HLVX
$105M
| $11.8M | 31.18% | 6,724,000 | – | – |
|
2
Wave Life Sciences
WVE
$1.53B
| $11M | 29.1% | 1,346,892 | – | – |
|
3
Ovid Therapeutics
OVID
$91M
| $8.89M | 23.42% | 7,531,996 | – | – |
|
4
Shattuck Labs
STTK
$47M
| $1.8M | 4.74% | 515,619 | – | – |
|
5
Equillium
EQ
$62.2M
| $1.51M | 3.99% | 1,824,977 | – | – |
|
6
Xilio Therapeutics
XLO
$36.3M
| $1.16M | 3.06% | 1,475,121 | – | – |
|
|
7
American Well
AMWL
$111M
| $737K | 1.94% | 77,733 -1,476,936 | -95% | -$14M |
|
|
TSBX
8
DELISTED
Turnstone Biologics
TSBX
| $499K | 1.31% | 895,824 | – | – |
|
|
9
Rani Therapeutics
RANI
$24.4M
| $439K | 1.16% | 203,190 -11,982 | -6% | -$25.9K |
|
10
Standard BioTools
LAB
$481M
| $31.9K | 0.08% | 16,515 | – | – |
|
|
11
Denali Therapeutics
DNLI
$2.23B
| – | – | -4,214,559 | Closed | -$97.9M |
|
|
12
Phathom Pharmaceuticals
PHAT
$864M
| – | – | -1,557,063 | Closed | -$16M |
|
|
AKLI
13
DELISTED
Akili, Inc. Common Stock
AKLI
| – | – | -738,819 | Closed | -$321K |
|